1,856
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Has the bloom gone out of lorcaserin following the CAMELLIA-TIMI61 trial?

Pages 261-264 | Received 23 Sep 2020, Accepted 30 Nov 2020, Published online: 31 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ana Pejčić, Slobodan M. Janković, Miralem Đešević, Refet Gojak, Snežana Lukić, Nenad Marković & Miloš Milosavljević. (2021) Novel and emerging therapeutics for genetic epilepsies. Expert Review of Neurotherapeutics 21:11, pages 1283-1301.
Read now

Articles from other publishers (2)

Aristea Sideri Gugger, Cara Dimino, Sunil K Panigrahi, Laurel Mayer, Richard M Smiley, Judith Korner & Sharon L Wardlaw. (2023) Defining Predictors of Weight Loss Response to Lorcaserin. The Journal of Clinical Endocrinology & Metabolism 108:9, pages 2262-2271.
Crossref
Yan Cai, Xiaolong Li, Hongli Zhou & Jiyin Zhou. (2022) The serotonergic system dysfunction in diabetes mellitus. Frontiers in Cellular Neuroscience 16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.